Structure-activity relationships of novel non-competitive mGluR1 antagonists: a potential treatment for chronic pain

Bioorg Med Chem Lett. 2007 Jan 15;17(2):486-90. doi: 10.1016/j.bmcl.2006.10.015. Epub 2006 Oct 11.

Abstract

A series of novel mGluR1 antagonists have been prepared. Incorporation of fragments derived from weak lead matter into a library led to enhanced potency in a new chemical series. A chemistry driven second library iteration, covering a greatly enhanced area of chemical space, maintained good potency and introduced metabolic stability.

MeSH terms

  • Animals
  • Binding, Competitive / drug effects
  • CHO Cells
  • Chemical Phenomena
  • Chemistry, Physical
  • Chronic Disease
  • Cricetinae
  • Cricetulus
  • Dose-Response Relationship, Drug
  • Glutamic Acid / pharmacology
  • Pain / drug therapy*
  • Pyrazines / chemical synthesis
  • Pyrazines / pharmacology
  • Rats
  • Receptors, Metabotropic Glutamate / antagonists & inhibitors*
  • Structure-Activity Relationship

Substances

  • Pyrazines
  • Receptors, Metabotropic Glutamate
  • metabotropic glutamate receptor type 1
  • Glutamic Acid